A research team has successfully combined adaptive laboratory evolution (ALE) with metabolic engineering to create a strain of Escherichia coli that produces succinic acid (SA) from glycerol at significantly higher yields.

A research team has engineered the nonconventional yeast Yarrowia lipolytica to produce cannabinoids and their analogs, offering a sustainable alternative to plant extraction.

A team of researchers has uncovered how subtle structural changes in terpene synthases can dramatically improve the biosynthesis of miltiradiene, a critical intermediate in the production of pharmacologically valuable compounds such as tanshinone IIA, triptolide, and carnosic acid.

A research team has developed an innovative platform for producing lactate-based biodegradable plastics by harnessing a phosphite dehydrogenase (PtxD)-driven NADH regeneration system in Escherichia coli.

A research team has developed the first reported bioproduction method for 3,4-methylenedioxymethamphetamine (MDMA, commonly known as Ecstasy) and related methamphetamine derivatives using a combination of yeast-based bioconversion, biocatalysis, and chemical reduction.